Clinical Trials Browser

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT04409223 2024-02-09

Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib

Phase 3 Terminated

185 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03729245 2023-04-11

A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)

Phase 3 Terminated

623 enrolled 14 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00520533 2022-10-12

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Phase 1 Terminated

8 enrolled 18 charts

Genitourinary

Carcinoma, Renal Cell, Mycobacterium Infections, Nontuberculous

NCT03641326 2022-04-19

Sunitinib in Sarcomas of the Central Nervous System

Phase 2 Terminated

5 enrolled 14 charts

CNSSarcoma

Brain Neoplasms, Gliosarcoma

NCT01620216 2021-11-04

Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Phase 2 Terminated

12 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02959554 2021-09-08

NIVOSWITCH

Phase 2 Terminated

49 enrolled

Genitourinary

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT01185366 2021-04-28

Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma

Phase 2 Terminated

73 enrolled 17 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00853125 2021-04-27

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Phase 2 Terminated

10 enrolled 8 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01190241 2020-11-20

TSAP

Phase NA Terminated

45 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT01673386 2020-10-27

TAURUS

Phase 2 Terminated

58 enrolled 7 charts

Genitourinary

Carcinoma, Renal Cell

NCT02315625 2020-09-09

Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

Phase 2 Terminated

16 enrolled 15 charts

EndocrineNET

Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT00905021 2020-07-24

EXTENT

Phase 1/2 Terminated

4 enrolled 6 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00616122 2020-01-13

Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Terminated

32 enrolled 10 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00975806 2019-11-25

Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma

Phase 1/2 Terminated

16 enrolled 13 charts

Genitourinary

Carcinoma, Renal Cell

NCT00859456 2019-11-04

Sunitinib in Certain Subtypes of Soft Tissue Sarcomas

Phase 2 Terminated

10 enrolled 6 charts

Sarcoma

NCT00408252 2019-09-19

Efficacy of SU 011248 in Head And Neck Carcinoma

Phase 2 Terminated

54 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT01391130 2019-07-23

A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Phase 2 Terminated

110 enrolled 14 charts

Genitourinary

Clear-cell metastatic renal cell carcinoma, Neoplasm Metastasis, Neoplasms

NCT01118351 2019-05-01

Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer

Phase 2 Terminated

19 enrolled 11 charts

Genitourinary

Urinary Bladder Neoplasms

NCT01502228 2019-03-05

PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma

Phase NA Terminated

14 enrolled 7 charts

Genitourinary

Carcinoma, Renal Cell

NCT01740154 2018-12-06

Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer

Phase NA Terminated

13 enrolled 7 charts

Genitourinary

Carcinoma, Renal Cell, Fatigue

NCT02560012 2018-10-12

Personalized Targeted Inhibitors Treatment in Renal Cell Cancer

Phase 2 Terminated

4 enrolled 3 charts

Genitourinary

Carcinoma, Renal Cell

NCT00953459 2018-07-26

Sunitinib Malate in Treating Patients With Small Cell Lung Cancer

Phase 2 Terminated

9 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT02386111 2018-07-26

A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Phase 1 Terminated

17 enrolled

Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms, Neoplasms by Histologic Type, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT02626754 2018-06-26